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The Third Department of Internal Medicine, Kanazawa University School of Medicine, Kanazawa, 
lapan 
There are clinically different types of eosinophilic pneumonia (EP) but no study to date has compared pulmonary 
inflammatory cells between different types of EP, such as acute eosinophilic pneumonia (AEP), chronic eosinophilic 
pneumonia (CEP) and drug-induced eosinophilic pneumonia (drug-EP). The present study compared broncho- 
alveolar lavage fluid (BALF) cell findings to elucidate whether the profiles of the pulmonary inflammatory cells were 
different among the three types of EP. 
Clinical records of 28 patients with EP, consisting of eight AEP patients, 10 CEP patients and 10 drug-EP 
patients, were examined retrospectively. The differential cell counts, the CD4+/CD8+ ratio of lymphocytes, the 
percentage of HLA-DR + in CD4 + and CD8 + lymphocytes, and the mean number of nuclear segmentations in 
eosinophils in BALF were compared among the three types of EP. 
The numbers of total cells, lymphocytes, neutrophils and eosinophils in BALF from patients with AEP were 
increased compared with those from normal subjects, and patients with CEP and drug-EP. The CD4+/CD8 + ratio 
of the BALF lymphocytes in patients with AEP, which exceeded 1.0 in all patients, was significantly higher than that 
in normal subjects. The percentages of HLA-DR+ cells in CD8+ lymphocytes in BALF from patients with CEP 
were significantly higher than those from patients with AEP and drug-EP. There was no significant difference in the 
mean number of nuclear segmentations in eosinophils in BALF among the three types of EP. 
The BALF cell findings in patients with EP showed some characteristics in accordance with type of EP. It is 
suggested that pulmonary neutrophils and lymphocytes, rather than eosinophils, may be related to the pathogenesis 
of the different types of EP. 
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Introduction 
Eosinophilic pneumonia (EP) has been defined as pulmon- 
ary infiltration of eosinophils independently of peripheral 
blood eosinophilia. This pulmonary disorder includes 
clinically different types of EP and different causes (l-6). 
Both acute eosinophilic pneumonia (AEP) (7) and chronic 
eosinophilic pneumonia (CEP) (8) have been described as 
idiopathic EP (5). There are some reports concerning the 
comparison of clinical features between AEP and CEP 
(9,lO). However, the differences in the profiles of pulmon- 
ary inflammatory cells between the two diseases remains 
unknown. Analysis of bronchoalveolar lavage fluid (BALF) 
cells is fundamentally important in diagnosis of EP. As it is 
considered that the findings of BALF cells reflect the 
inflammatory processes of the lungs, it is suggested that the 
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different types of EP may have distinctive profiles of BALF 
cells. Drug-induced EP (drug-EP), which has a specific 
aetiology, is common. The authors considered that it is 
important to compare idiopathic EP with aetiology- 
proven EP. The present study was conducted to elucidate 
the differences of BALF cell findings among AEP, CEP and 
drug-EP. 
Subjects and Methods 
SUBJECTS 
Twenty-eight patients with EP, consisting of eight patients 
with AEP (seven men and one woman, mean age 24.9 + 9.8 
years, all smokers), 10 patients with CEP (seven men and 
three women, mean age 58.6 & 19.6 years, five smokers and 
five non-smokers) and 10 patients with drug-EP (five men 
and five women, mean age 42.3 I-t 19.9 years, four smokers 
and six non-smokers), were included in this study. Each 
patient was diagnosed and treated at Kanazawa University 
Hospital or its related hospitals between 1989 and 1995. 
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Five of the patients with AEP (1 l), and three of the patients 
with drug-EP (12,13) were included in the authors’ previous 
reports. Each patient with AEP met the following diagnos- 
tic criteria: acute febrile illness of less than 7 days duration; 
hypoxaemia; diffuse pulmonary infiltrates on chest X-ray 
films; increased percentage of eosinophils in BALF; absence 
of possible causes; and either spontaneous improvement or 
prompt response to corticosteroid therapy with no relapse. 
Five patients were treated with corticosteroids. None of 
them had a history of bronchial asthma. The diagnosis of 
CEP was made based on the following diagnostic criteria: 
typical clinical features consistent with CEP (5) (fever, 
malaise, night sweats, weight loss, anorexia, cough, 
sputum); dense and multiple foci of consolidation in the 
peripheral lung fields on chest X-ray films; increased 
percentage of eosinophils in BALF; absence of possible 
causes; and prompt response to corticosteroid therapy. All 
patients were treated with corticosteroids. Five patients had 
bronchial asthma. Attention was paid to the differential 
diagnosis of allergic bronchopulmonary aspergillosis, espe- 
cially in patients complicated with bronchial asthma; it was 
ruled out by serological and sputum examinations and skin 
test. Five patients had relapse of their symptoms and chest 
radiographic shadows. It is reported that the classification 
of CEP and AEP by chest radiographic findings fully 
coincides with that by the clinical course (10). Therefore, 
the authors attached importance to chest radiographic 
findings. The patients with drug-EP satisfied the following 
diagnostic criteria: fever or some respiratory symptoms; 
diffuse pulmonary infiltrates on chest X-ray films; increased 
percentage of eosinophils in BALF; prompt improvement 
after cessation of the causative drug; absence of other 
possible causes; positive reaction in lymphocyte stimulation 
assays; or recurrence of the symptoms with the drug 
challenge. The causative drugs were minocycline hydro- 
chloride in five patients, and lomefloxacin hydrochloride, 
piperacillin sodium, cefixime, cefodizime and ofloxacin, 
each in one patient. One patients with drug-EP had bron- 
chial asthma. The laboratory data in the patients with EP 
on admission were as following (mean & standard devia- 
tion). AEP: WBC 16 688.0 j, 4573.7 cells ul - ‘, eosinophils 
6.0 & 14.9%, CRP 10.6 & 4.0 mg dl-’ IgE 1352.0 f 
986.8 IU ml-’ PaO, 41.1 f 17.8 mmHg; CEP: WBC 
7533.0 rt 2220.0 cells ul- ‘, eosinophils 15.1 & 16.9%, CRP 
3.6&2.2mg dl-‘, IgE 398.0&646,OIU ml-‘, PaO, 
74.9 + 12.3 mmHg; drug-EP: WBC 9562.5 & 3574.9 cells 
1-11-l, eosinophils 16.9 + 20.0%, CRP 4.1 & 6.7 mg dl - ‘, 
IgE 599.1 & 640.8 IU ml ~ i, PaO, 75.0 * 11.4 mmHg. 
As control, the BALF obtained from 10 normal subjects 
(nine men and one woman, mean age 50.5 & 17.9 years, 
seven smokers and three non-smokers) was used. 
BRONCHOALVEOLAR LAVAGE 
DIFFERENTIAL CELL COUNTS IN BALF 
After part of the BALF was diluted with an equal volume 
of Turk solution, cells were counted in a Btirker chamber. 
After the remaining BALF was passed through a double 
layer of Dacron net, cells were pelleted at 1500 rpm for 
10 min and resuspended in 10 ml of RPMI-1640 (Grand 
Island Biological C., Grand Island, NY, U.S.A.). The fluid 
was resuspended to a concentration of 2 x lo5 cells ml ~ I. 
Smears for differential counts were prepared by cyto- 
centrifugation (Cytopin 2, Shadon Southern Instruments, 
Sewickleyo, U.S.A.) at 800 rpm for 10 min. After staining 
with May-Grtinwald-Giemsa, differential cell count was 
done in 300 cells. 
LYMPHOCYTE SUBSETS 
Each cell suspension was adjusted to a concentration of 
2 x lo7 cells ml ~ i. For assay, 10 ul of the monoclonal 
antibody was added at the proper dilution to 100 ul of the 
cell suspension. Cells were incubated at 4°C for 30 min, 
washed twice in phosphate-buffered saline, and then resus- 
pended in 0.3 ml of RPMI-1640. They were then analysed 
for CD4+, CD8+, CD4+ and human leukocyte 
antigen-DR (HLA-DR) + and CD8 + and HLA-DR+ lym- 
phocytes, using a flow cytometer (FACScan, Becton 
Disckinson, Mountain View, CA, U.S.A.). Monoclonal 
antibodies that recognized CD8 [fluorescein isothiocyanate 
(FITC)-conjugated Leu2], CD4 (FITC-conjugated Leu3) 
and HLA-DR Lphycoerythrin (PE)-conjugated HLA-DR] 
were provided by Becton Disckinson. In each analysis, cells 
stained by FITC- and PE-conjugated non-reactive mouse 
IgG (Becton Disckinson) were employed as negative con- 
trol. Flow cytometric analyses were processed by SimulSET 
software in a FACScan. Appropriate fractions of lym- 
phocytes were selected by gating on two-dimension display, 
on forward scatter and side scatter. 
NUCLEAR SEGMENTATION OF EOSINOPHILS 
IN BALF 
Nuclear segmentation of 200 BALF eosinophils was 
counted on slides prepared by cytocentrifugation (Cytopin 
2, Shadon Southern Instruments, Sewickleyo, U.S.A.) at 
800 rpm for 10min and stained with May-Griinwald- 
Giemsa. The mean number of nuclear segmentations per 
eosinophil was calculated in each subject. 
STATISTICAL ANALYSIS 
Bronchoalveolar lavage was performed in the acute phase Data were expressed as means f standard deviation (SD) of 
without corticosteroid therapy. It was carried out in the the mean. Unpaired t-test was used to compare the BALF 
lobe with shadow using three 50 ml aliquots of physiologic cell findings between any pairs of normal subjects and 
saline solution. A part of the recovered fluid was used for patients with AEP, CEP and drug-EP. A level of PcO.05 
bacteriologic culture and cytological examination. was considered statistically significant. 
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FIG. 2. CD4+/CD8+ ratio of lymphocytes in bronchoalveolar lavage fluid (BALF) and peripheral blood (PB) in 
patients with acute eosinophilic pneumonia (AEP), chronic eosinophilic pneumonia (CEP) and drug-induced 
eosinophilic pneumonia (drug-EP). Each open square with vertical bar represents mean + SD. *P<O.O5 compared 
with normal subjects. 
Results 
DIFFERENTIAL CELL COUNTS IN BALF 
The absolute numbers of BALF cells are shown in Fig. 1. 
The number of total cells in patients with AEP, CEP and 
drug-EP were significantly increased compared with that in 
normal subjects. The number of lymphocytes in patients 
with AEP and CEP were significantly increased compared 
with that in normal subjects. The number of neutrophils in 
patients with AEP was significantly increased compared 
with that in normal subjects. The numbers of total cells, 
lymphyocytes, neutrophils and eosinophils in patients with 
AEP were significantly higher than those in patients with 
CEP or drug-EP, respectively. 
CD4+/CDS+ RATIOS OF LYMPHOCYTES IN 
BALF 
The CD4+lCD8+ ratios of lymphocytes in BALF and 
peripheral blood (PB) are shown in Fig. 2. The CD4+/ 
CD8+ ratio in the BALF from patients with AEP 
(2.3 + 0.8) was significantly higher than that from normal 
subjects (1.4 f 0.7). The CD4+/CD8+ ratio in patients 
with CEP or drug-EP did not differ from that in normal 
subjects. The CD4+/CD8+ ratio in BALF from patients 
with AEP was significantly higher than that from patients 
with drug-EP. 
The CD4+/CD89+ ratio of lymphocytes in PB was not 
different among patients with AEP, CEP and drug-EP and 
normal subjects. 
PERCENTAGE OF HLA-DR+IN CD4+ AND 
CDs+ LYMPHOCYTES IN BALF 
Percentages of HLA-DR+ in CD4+ and CD8+ lym- 
phocytes in BALF and PB are shown in Fig. 3. Both the 
percentages of HLA-DR+ in CD4+ and CD8+ cells in 
BALF from patients with CEP were significantly increased 
compared with those from normal subjects. The percentage 
of HLA-DR+ in CD8+ cells in BALF from patients with 
CEP was significantly higher than that from patient with 
AEP and drug-EP. 
The percentage of HLA-DR+ in CD4+ or CD8+ lym- 
phocytes in PB did not differ among patients with AEP, 
CEP and drug-EP and normal subjects. 
NUCLEAR SEGMENTATION OF EOSINOPHILS 
IN BALF 
Mean numbers of nuclear segmentations in eosinophils in 
BALF from patients with AEP, CEP and drug-EP are 
shown in Fig. 4. There were no significant differences in the 
number of nuclear segmentations among the three patient 
groups. 
Discussion 
The present study compared the profiles of pulmonary 
inflammatory cells among AEP, CEP and drug-EP. In the 
results, the numbers of total cells, eosinophils and lym- 
phocytes in BALF from patients with AEP, CEP and 
drug-EP were increased compared with those from 
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FIG. 3. Percentage of HLA-DR+ in CD4+ and CD8+ lymphocytes in bronchoalveolar lavage fluid (BALF) and 
peripheral blood (PB) in patients with acute eosinophilic pneumonia (AEP), chronic eosinophilic pneumonia (CEP) and 
drug-induced eosinophilic pneumonia (drug-EP). Each open square with bar represents mean z!= SD. *P<O.O5, ““PcO.01 
compared with normal subjects. 
normal subjects. The authors consider that the increases of severe illness. Indeed, in this study, the illness was most 
eosinophils and lymphocytes in the lungs are fundamental severe in the patients with AEP. It is suggested that the 
common profiles in all three types of EP. However, the degree of inflammatory cell infiltration, especially neu- 
number of neutrophils in BALF from patients with AEP trophils, in the lungs is linked to the clinical condition in the 
was increased significantly compared with those from patients with EP. There is no report showing the increase of 
normal subjects and patients with CEP and drug-EP. In eosinophils and neutrophils in BALF from AEP compared 
addition, the numbers of eosinophils and lymphocytes were with those from CEP. In the four patients with AEP 
also increased significantly in patients with AEP compared reported by Allen et al. (7) the percentage of neutrophils in 
with CEP and drug-EP. Therefore, the inflammatory cell BALF on admission was increased in three patients, and 
profile in the lungs of patients with AEP may be character- the neutrophil percentage was decreased during the recov- 
ized by the intensive infiltration, especially the increase of ery phase in the three patients. So, the present authors 
neutrophils. Clinically, most of the patients with AEP have suspect that the discrepancy of BAL neutrophilia in AEP 
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FIG. 4. Mean number of nuclear segmentation of eosi- 
nophils in bronchoalveolar lavage fluid (BALF) from 
patients with acute eosinophilic pneumonia (AEP), 
chronic eosinophilic pneumonia (CEP) and drug-induced 
eosinophilic pneumonia (drug-EP). Each open square 
with vertical bar represents mean i SD. 
may be due to the difference of the disease phase (acute VS. 
recovery) when BAL was performed. Otherwise, as all of 
the patients with AEP were smokers, it may be claimed that 
smoking affects the BALF cell findings. There was the same 
tendency when the BALF cell findings in the smoking 
patients with CEP and drug-EP were compared with those 
in AEP (data not shown). On the other hand, the authors 
also suspect that smoking in young-aged men and women 
may be related to AEP, because most of the patients with 
AEP studied were young smokers with a little experience of 
smoking. The patients with AEP described in previous 
reports are also comparatively young, but there is insuffi- 
cient information concerning their smoking state. Future 
studies to clarify the association between smoking and AEP 
are needed. 
The CD4+/CDS+ ratio of lymphocytes in the BALF 
from patients with AEP was increased compared with those 
from normal subjects and patients with CEP and drug-EP. 
In addition, although there was no certain tendency in the 
CD4 +/CD8 + ratio in the patients with CEP or drug-EP, 
the ratio exceeded 1.0 in all patients with AEP. It is 
suspected that a variety of drugs and/or different types of 
allergic reactions may be responsible for the indefinite 
CD4+/CD8+ ratio of BALF lymphocytes in drug-EP. On 
the other hand, AEP and CEP are idiopathic or aetiology 
unknown. It is characteristic of summer-type hyper- 
sensitivity pneumonitis that the CD4+/CD8+ ratios of 
BALF lymphocytes are decreased below 1.0 (14). From 
these findings, it is suspected that the uniform increase in 
the CD4 +/CDS + ratios of BALF cells in AEP indicates an 
antigen and/or allergic reaction as the aetiology. 
Next the percentage of HLA-DR+ in CDS + lym- 
phocytes in the BALF from patients with CEP was signifi- 
cantly greater than that from patients with AEP and 
drug-EP, suggesting that activated lymphocytes, especially 
activated suppresser T-cells, in BALF from patients with 
CEP are increased. Although the number of lymphocytes in 
BALF from patients with CEP was lower than that from 
patients with AEP, the lymphocytes in BALF from patients 
with CEP may be characterized by the increased activation 
of pulmonary suppresser T-cells. In addition, the percent- 
age of HLA-DR+ in CDs+ lymphocytes in the peripheral 
blood from patients with CEP and drug-EP tended to be 
increased compared with that in normal subjects and 
patients with AEP. Causative drugs arrive at the lungs 
through the venous route in drug-EP, resulting in systemic 
immunologic reactions such as the increased percentage of 
HLA-DR + in CD8 + lymphocytes in the peripheral blood. 
There was no difference in lymphocyte subset in the periph- 
eral blood between the patients with AEP and normal 
subjects, suggesting that a causative antigen may arrive at 
the lungs through the respiratory tract but not through the 
venous route, or allergic reaction may be localized in the 
lungs in AEP. 
Chihara et al. (15) showed hypodensity and nuclear 
hypersegmentation of pulmonary eosinophils in EP. In 
addition, they reported that some chemo-attractants and 
cytokines could induce nuclear hypersegmentation of eosi- 
nophils (16). Previously, the present authors have observed 
that the changes in mean number of nuclear segmentations 
of eosinophils in BALF were closely linked with the disease 
activity of EP (unpubl. data). It is speculated that this 
phenomenon may be associated with the increase of some 
mediators and/or cytokines which activate eosinophils in 
the lungs. The present study showed that there were no 
significant differences in the mean number of nuclear seg- 
mentations in eosinophils in BALF among AEP, CEP and 
drug-EP. Therefore, it is thought that the nuclear hyper- 
segmentation of eosinophils in BALF, one of the indicators 
for activated eosinophils, is observed commonly regardless 
of different types of EP. It is suspected that there may be 
no difference in participating mediators and/or cytokines 
activating eosinophils in the lungs among the three types 
of EP. 
In conclusion, the BALF cell findings in patients with EP 
showed some distinctive characteristics in accordance with 
the type of EP. It is suggested that neutrophils and lym- 
phocytes rather than eosinophils in the lungs may be related 
to the pathogensis of each type of EP. Consequently, it is 
recommended that the function of BALF cells should be 
analysed in accordance with each type of EP in future 
studies. 
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